OSLO, Norway, April 8, 2016 -- Notice is hereby given that the Annual General Meeting of Norsk Hydro ASA will be held at the company's office at Vækerø, Drammensveien 260, 0283 Oslo, on Monday 2 May 2016 at 2 p.m (CET).
The full notice, agenda and appendices are attached.
All relevant documents can be found on www.hydro.com/generalmeeting
Investor contact
Contact Pål Kildemo
Cellular +47 97096711
E-mail [email protected]
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Notice AGM 2016 http://hugin.info/106/R/2001362/738401.pdf
Appendix 1 Financial statements and Board of Directors Report 2015 http://hugin.info/106/R/2001362/738402.pdf
Appendix 2 Notice of attendance AGM 2016 http://hugin.info/106/R/2001362/738403.pdf
Appendix 3 and Appendix 4 http://hugin.info/106/R/2001362/738581.pdf
HUG#2001362


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Italy Fines Apple €98.6 Million Over App Store Dominance
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



